Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/542
Full metadata record
DC FieldValueLanguage
dc.contributor.authorS.R.Kuranbayeva, G.S.Rakhimbayeva-
dc.date.accessioned2020-03-12T05:36:07Z-
dc.date.available2020-03-12T05:36:07Z-
dc.date.issued2019-
dc.identifier.urihttp://repository.tma.uz/xmlui/handle/1/542-
dc.description.abstractThe study was based on data from 103 patients with HIV infection (54.4% of women and 45.6% of men) dispensary registered, aged from 20 to 45 years old. Neuropsychological studies of patients with HIV infection were carried out using special tests, such as: Wechsler Memory Scale (WMS), 7 subtests, Schulte table, and “Incomplete Outlines of Objects” The efficacy of citicoline (1000 mg / day) when added to basic HIV treatment was studied in 53 patients. The comparison group consisted of 50 HIV patients who did not receive neuroprotective therapy. The efficacy of treatment was assessed according to the CGI clinical scale (the scale of the overall clinical impression - Clinical Global Impression).en_US
dc.language.isootheren_US
dc.publisherTashkenten_US
dc.subjectAIDS, neurogical sydrome, diagnostic, treatmenten_US
dc.titlePrinciples of therapeutic strategy for neurological syndromes in HIV patientsen_US
dc.typeArticleen_US
Appears in Collections:Thesis, Articles

Files in This Item:
File Description SizeFormat 
172.pdfPrinciples of therapeutic strategy for neurological syndromes in HIV patients168.7 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.